Evidence map›Paper›PMID 28210393›Full record

ArticleThe Journal of clinical and aesthetic dermatology2016

Has Vitamin D Had Its "Time In The Sun" For Melanoma?

Christopher J Huerter, Adam Vaudreuil, Devendra K Agrawal, Austin Huy Nguyen

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 79% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christopher J HuerterDivision of Dermatology and Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, Nebraska.
Adam VaudreuilDivision of Dermatology and Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, Nebraska.
Devendra K AgrawalDivision of Dermatology and Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, Nebraska.
Austin Huy NguyenDivision of Dermatology and Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, Nebraska.
Creighton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growing evidence suggests a pivotal role for vitamin D in cancers, particularly melanoma. The broad immunologic effects of vitamin D and its signaling axis make for a complex interplay between tumor cells and the immune system. Preclinical evidence suggests vitamin D to have protective effects in melanoma oncogenesis and progression, creating a potential role for vitamin D supplementation in cancer prevention and/or adjuvant therapy. In this commentary, the authors highlight studies of vitamin D in melanoma with clinical implications and call for large clinical trials to definitively determine the role of supplementation in patients to prevent and help treat melanoma.

Identifiers

PMID28210393
PMCPMC5300721
OpenAlexW2589356891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.